GlassScriptPhysician profile
Stephanie R Phillips
NPI 1710370135
$11,725.79
in general payments reported to CMS, 2019-2025
59 companies · $2,524 in 2025
The $2,524 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,529 · 2022: $2,704 · 2023: $1,470 · 2024: $2,498 · 2025: $2,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,492.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,710.60 | 2021-2025 | |
| Novo Nordisk INC | $1,117.58 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $735.04 | 2021-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $650.01 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $546.06 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $462.15 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lilly USA, LLC | $462.09 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $461.08 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $456.09 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.88 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Antares Pharma, INC. | $381.50 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $302.49 | 2021-2025 | Xifaxan, Trulance |
| Lundbeck LLC | $300.78 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $294.22 | 2022-2025 | Caplyta |
| Merck Sharp & Dohme LLC | $204.33 | 2021-2025 | Gardasil 9, Capvaxive |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $199.28 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Daiichi Sankyo INC. | $189.23 | 2021-2023 | Injectafer |
| Eisai INC. | $184.15 | 2021-2022 | |
| Alkermes, INC. | $164.70 | 2022-2024 | Aristada, Lybalvi, Vivitrol |
| Dexcom, INC. | $158.39 | 2022-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $151.59 | 2021-2022 | |
| Abbott Laboratories | $146.69 | 2021-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $143.86 | 2021-2023 | Seglentis |
| Phathom Pharmaceuticals, INC. | $128.79 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $117.29 | 2023-2025 | Auvelity |
| Dova Pharmaceuticals | $116.75 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $111.67 | 2021 | |
| Idorsia Pharmaceuticals US INC | $105.91 | 2022-2024 | Quviviq |
| Astellas Pharma US INC | $102.89 | 2024-2025 | Veozah, Vesicare |
| Ardelyx, INC. | $93.34 | 2024-2025 | Ibsrela |
| Ibsa Pharma INC. | $87.68 | 2021-2025 | Licart, Tirosint, Flector |
| Exact Sciences Corporation | $87.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $86.97 | 2021-2023 | |
| Almatica Pharma LLC | $86.82 | 2022-2024 | Loreev Xr, Teriparatide |
| Bayer Healthcare Pharmaceuticals INC. | $85.53 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.79 | 2021-2025 | Trintellix |
| Currax Pharmaceuticals LLC | $53.01 | 2021-2023 | Nexletol, Onzetra Xsail, Nexlizet |
| Harmony Biosciences LLC | $49.53 | 2024-2025 | |
| Ironwood Pharmaceuticals, INC | $45.53 | 2022-2024 | |
| Bausch Health US, LLC | $44.53 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $44.35 | 2021-2025 | Spravato |
| Vanda Pharmaceuticals INC. | $37.48 | 2025 | Fanapt |
| Sanofi-Aventis U.S. LLC | $36.11 | 2022-2025 | |
| Corcept Therapeutics | $31.39 | 2025 | Korlym |
| Neos Therapeutics, LP | $30.08 | 2024 | Adzenys Xr-Odt |
| Jazz Pharmaceuticals INC. | $29.34 | 2021 | |
| Scilex Pharmaceuticals INC. | $28.01 | 2021 | |
| Adlon Therapeutics L.P. | $24.56 | 2021 | |
| Corium, LLC | $17.29 | 2024 | Azstarys |
| Si-Bone, INC. | $17.04 | 2024 | |
| Ucb, INC. | $16.15 | 2022 | |
| Nevro Corp. | $15.99 | 2023 | Senza |
| Allergan, INC. | $15.98 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.27 | 2023 | Gvoke Hypopen |
| Collegium Pharmaceutical, INC. | $14.53 | 2021 | |
| Endo Pharmaceuticals INC. | $13.94 | 2021 | |
| Vivus LLC | $13.84 | 2021 | |
| Redhill Biopharma INC. | $13.20 | 2021 | |
| Genentech USA, INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.